Salud financiera de hoja de balance de Venus Remedies
Salud financiera controles de criterios 6/6
Venus Remedies tiene un patrimonio de accionistas total de ₹4.9B y una deuda total de ₹409.1M, lo que sitúa su ratio deuda-patrimonio en 8.3%. Sus activos y pasivos totales son ₹6.6B y ₹1.7B respectivamente. El BAIT de Venus Remedies es de ₹233.7M, por lo que su ratio de cobertura de intereses es de -5.7. Tiene efectivo e inversiones a corto plazo que ascienden a ₹1.3B.
Información clave
8.3%
Ratio deuda-patrimonio
₹409.10m
Deuda
| Ratio de cobertura de intereses | -5.7x |
| Efectivo | ₹1.34b |
| Patrimonio | ₹4.94b |
| Total pasivo | ₹1.66b |
| Activos totales | ₹6.60b |
Actualizaciones recientes sobre salud financiera
Venus Remedies (NSE:VENUSREM) Could Easily Take On More Debt
Jun 13
Venus Remedies (NSE:VENUSREM) Seems To Use Debt Rather Sparingly
Jun 03Is Venus Remedies (NSE:VENUSREM) Using Too Much Debt?
May 31Is Venus Remedies (NSE:VENUSREM) Using Too Much Debt?
Feb 01We Think Venus Remedies (NSE:VENUSREM) Is Taking Some Risk With Its Debt
Jan 14Is Venus Remedies (NSE:VENUSREM) A Risky Investment?
Sep 22Recent updates
Shareholders May Not Be So Generous With Venus Remedies Limited's (NSE:VENUSREM) CEO Compensation And Here's Why
Sep 17Venus Remedies Limited (NSE:VENUSREM) Held Back By Insufficient Growth Even After Shares Climb 26%
Jun 14Venus Remedies (NSE:VENUSREM) Could Easily Take On More Debt
Jun 13Venus Remedies Limited (NSE:VENUSREM) Not Doing Enough For Some Investors As Its Shares Slump 26%
Mar 14Calculating The Fair Value Of Venus Remedies Limited (NSE:VENUSREM)
Oct 31Venus Remedies (NSE:VENUSREM) Seems To Use Debt Rather Sparingly
Jun 03Estimating The Fair Value Of Venus Remedies Limited (NSE:VENUSREM)
Jul 15Is Venus Remedies (NSE:VENUSREM) Using Too Much Debt?
May 31I Ran A Stock Scan For Earnings Growth And Venus Remedies (NSE:VENUSREM) Passed With Ease
Mar 30Why Investors Shouldn't Be Surprised By Venus Remedies Limited's (NSE:VENUSREM) 25% Share Price Plunge
Feb 24Is Venus Remedies (NSE:VENUSREM) Using Too Much Debt?
Feb 01Here's Why We Think Venus Remedies (NSE:VENUSREM) Is Well Worth Watching
Nov 16Venus Remedies Limited's (NSE:VENUSREM) Stock Is Going Strong: Have Financials A Role To Play?
Mar 11We Think Venus Remedies (NSE:VENUSREM) Is Taking Some Risk With Its Debt
Jan 14Does Venus Remedies's (NSE:VENUSREM) Statutory Profit Adequately Reflect Its Underlying Profit?
Nov 23Is Venus Remedies (NSE:VENUSREM) A Risky Investment?
Sep 22Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹3.9B) de VENUSREM superan a sus pasivos a corto plazo (₹1.0B).
Pasivo a largo plazo: Los activos a corto plazo de VENUSREM (₹3.9B) superan a sus pasivos a largo plazo (₹652.1M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: VENUSREM tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de VENUSREM ha pasado de 57% a 8.3% en los últimos 5 años.
Cobertura de la deuda: La deuda de VENUSREM está bien cubierta por el flujo de caja operativo (159.7%).
Cobertura de intereses: VENUSREM gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.